IndiaFilingsIndiaFilings
India FlagRegister India Company
UAE FlagRegister UAE Company
USA FlagRegister USA Company

Avdumber Drug LLP

LLPIN : ACB-2592|ROC: RoC-MumbaiActive
Last Updated On : 23-05-2023
LLPINACB-2592
LLP NameAvdumber Drug LLP
Number of Partners3
Number of Designated Partners3
ROC CodeRoC-Mumbai
Date of Incorporation22-05-2023
Registered AddressShop No.02, Kamakshi Dham CHS, Plot No.213216 Sector 19, Koparkhairne, Navi-Mumbai Thane Thane Thane Maharashtra 400709
Email IDavdumberdrugllp@gmail.com
Total Obligation of Contribution50,000
Main division of business activity to be carried out in India46
LLP StatusActive

Directors / Signatory Details

DIN / PANNameBegin Date
10171889LOCHAN BALKRISHNA DABHADE22-05-2023
10171890ASHWINI MAHADEV KADAM22-05-2023
10171891NAINA AANKUSH KADAM22-05-2023
Avdumber Drug LLP is a Limited Liability Partnership (LLP) governed by the LLP Act, 2008. Registered under the Registrar of Companies RoC-Mumbai, it operates as a non-government entity. According to the Ministry of Corporate Affairs (MCA), this LLP was incorporated on 22-05-2023 and last updated on 23-05-2023. Its LLP Identification Number (LLPIN) is , and the registration number is . Currently, its eFiling status is listed as “Active” as per MCA records.
From a financial standpoint, Avdumber Drug LLP has a total contribution of INR 50,000. Details of the latest financial filings, such as the Statement of Accounts and Solvency or Annual Returns, are unavailable, indicating limited publicly disclosed financial data.
The registered office address is Shop No.02, Kamakshi Dham CHS, Plot No.213216 Sector 19, Koparkhairne, Navi-Mumbai Thane Thane Thane Maharashtra 400709. Correspondence or inquiries may be sent to the official email address, avdumberdrugllp@gmail.com.
For those interested in further details, below are some frequently asked questions:
Disclaimer

IndiaFilings is not affiliated with any companies listed on this website and does not represent them. Please contact the respective company directly for their inquiries.